Notice2025-01959

Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Previously Approved Collection; Recordkeeping for Electronic Prescriptions for Controlled Substances

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
January 30, 2025

Issuing agencies

Justice Department

Abstract

The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 19 (Thursday, January 30, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 19 (Thursday, January 30, 2025)]
[Notices]
[Pages 8537-8538]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-01959]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0049]


Agency Information Collection Activities; Proposed eCollection 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Recordkeeping for Electronic Prescriptions for Controlled 
Substances

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995.

DATES: Comments are encouraged and will be accepted for 30 days until 
March 3, 2025.

FOR FURTHER INFORMATION CONTACT: If you have comments especially on the 
estimated public burden or associated response time, suggestions, or 
need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Heather E. 
Achbach, Regulatory Drafting and Policy Support Section, Drug 
Enforcement Administration; Mailing Address: 8701 Morrissette Drive, 
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email: 
<a href="/cdn-cgi/l/email-protection#b6f2f3f798e6e4f7f6d2d3d798d1d9c0"><span class="__cf_email__" data-cfemail="3c78797d126c6e7d7c58595d125b534a">[email&#160;protected]</span></a> or <a href="/cdn-cgi/l/email-protection#79311c180d111c0b573c57381a111b181a11391d1c18571e160f"><span class="__cf_email__" data-cfemail="eea68b8f9a868b9cc0abc0af8d868c8f8d86ae8a8b8fc0898198">[email&#160;protected]</span></a>.

SUPPLEMENTARY INFORMATION: This proposed information collection was 
previously published in the Federal Register on November 26, 2024, at 
89 FR 93348, allowing for a 60-day comment period. The 60-day notice 
was also mistitled as Revision without

[[Page 8538]]

Change of a Previously Approved Collection. The correct title for the 
60-Day notice is Extension without Change of a Previously Approved 
Collection. Written comments and suggestions from the public and 
affected agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and/or
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Written comments and recommendations for this information 
collection should be submitted within 30 days of the publication of 
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. 
Find this particular information collection by selecting ``Currently 
under 30-day Review--Open for Public Comments'' or by using the search 
function and entering either the title of the information collection or 
the OMB Control Number 1117-0049. This information collection request 
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view 
Department of Justice, information collections currently under review 
by OMB.
    DOJ seeks PRA authorization for this information collection for 
three (3) years. OMB authorization for an ICR cannot be for more than 
three (3) years without renewal. The DOJ notes that information 
collection requirements submitted to the OMB for existing ICRs receive 
a month-to-month extension while they undergo review.

Overview of This Information Collection

    1. Type of Information Collection: Extension without change of a 
currently Approved Collection.
    2. Title of the Form/Collection: Recordkeeping for Electronic 
Prescriptions for Controlled Substances.
    3. Agency form number, if any, and the applicable component of the 
Department of Justice sponsoring the collection: No Form number is 
associated with this collection. The applicable component within the 
Department of Justice is the Drug Enforcement Administration, Diversion 
Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, Local, and tribal governments.
    Abstract: DEA is requiring that each registered practitioner apply 
to an approved credential service provider approved to obtain identity 
proofing and a credential. Hospitals and other institutional 
practitioners may conduct this process in-house as part of their 
credentialing. For practitioners currently working at or affiliated 
with a registered hospital or clinic, the hospital/clinic have to check 
a government-issued photographic identification. This may be done when 
the hospital/clinic issues credentials to new hires or newly affiliated 
physicians. For individual practitioners, two people need to enter 
logical access control data to grant permissions for practitioners 
authorized to approve and sign controlled substance prescriptions using 
the electronic prescription application. For institutional 
practitioners, logical access control data is entered by two people 
from an entity within the hospital/clinic that is separate from the 
entity that conduct identity proofing in-house. Similarly, pharmacies 
have to set logical access controls in the pharmacy application so that 
only authorized employees have permission to annotate or alter 
prescription records. Finally, if the electronic prescription or 
pharmacy application generates an incident report, practitioners, 
hospitals/clinics, and pharmacies have to review the incident report to 
determine if the event identified by the application represents a 
security incident.
    5. Obligation to Respond: Mandatory.
    6. Total Estimated Number of Respondents: 158,884.
    7. Estimated Time per Respondent: 1.043 hours.
    8. Frequency: 1 per year.
    9. Total Estimated Annual Time Burden: 107,733 hours.
    10. Total Estimated Annual Other Costs Burden: $0.
    If additional information is required, contact: Darwin Arceo, 
Department Clearance Officer, Policy and Planning Staff, Justice 
Management Division, United States Department of Justice, Two 
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.

    Dated: January 27, 2025.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2025-01959 Filed 1-29-25; 8:45 am]
BILLING CODE 4410-09-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on January 30, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.